Top Industry Leaders in the Epilepsy Diagnosis Treatment Market
Latest Epilepsy Diagnosis & Treatment Companies Updates:
Bio-Techne acquires BioLegend: This strategic move strengthens Bio-Techne's position in neuroscience research, including the development of tools for epilepsy diagnosis and treatment.
Neuropace partners with Mayo Clinic to develop AI-powered seizure prediction algorithms: This collaboration aims to leverage Mayo Clinic's expertise in epilepsy and Neuropace's technology to create personalized seizure prediction and prevention systems.
Epilepsy Foundation approves seizure response dog training program: This initiative expands access to trained seizure response dogs, a valuable tool for some individuals with epilepsy.
BrainSpec introduces the LGN-100 neurostimulation device: This non-invasive device received FDA approval for treating intractable epilepsy and offers a potential alternative to surgery for some patients.
List of Epilepsy Diagnosis & Treatment Key companies in the market:
- Pfizer, Inc. (US)
- Siemens Ltd. (Germany)
- Johnson & Johnson Services, Inc. (US)
- UCB Pharma Ltd. (UK)
- Natus Medical Incorporated. (US)
- Shire (Republic of Ireland)
- Abbott (US)
- NeuroWave Systems Inc. (US)
- GlaxoSmithKline plc (UK)
- Medtronic (US)